However, given the somewhat disappointing failure of therapies targeting VEGF in cancer, it appears that, at least in the case of tumor angiogenesis, other growth factors can suffice in the absence of VEGF signaling (Grépin and Pagès 2010; Khan and Roy 2016; Jászai and Schmidt 2019). Here, VEGFA is linked to cancer.